← Back to Clinical Trials
Recruiting NCT05827406

NCT05827406 A Useful Support System for Psychiatric Diagnostics and Follow-up in Adult Psychiatry and Primary Care (ASPP)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05827406
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Mental Disorder
Study Type OBSERVATIONAL
Enrollment 2,200 participants
Start Date 2023-05-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,200 participants in total. It began in 2023-05-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Psychiatric diagnostics involve collecting information about a patient's symptoms, age of onset, development over time, relation to external stress, and ability to function and experience suffering. This information is classified using ICD (World Health Organisation) and DSM (American diagnosis system). Currently, there is a lack of a scientifically evaluated system to support these diagnostics. This project seeks to develop and evaluate a set of self-assessment scales which collect and classify relevant data and serve as support for clinicians. These scales are made up of questions about typical psychiatric symptoms, which are assessed and evaluated using a statistical method (Item Response Theory). After testing and evaluation, a scale could consist of approximately 10 items or less. The scales are then tested together to see if the number of items and scales can be reduced further.

Eligibility Criteria

Inclusion Criteria: * Patients with psychiatric problems Exclusion Criteria: * None

Contact & Investigator

Central Contact

Mats O Adler, MD

✉ mats.adler@ki.se

📞 +46707717977

Principal Investigator

Mats O Adler, MD

PRINCIPAL INVESTIGATOR

Karolinska Institutet, Department of Clinical Neuroscience

Frequently Asked Questions

Who can join the NCT05827406 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Mental Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05827406 currently recruiting?

Yes, NCT05827406 is actively recruiting participants. Contact the research team at mats.adler@ki.se for enrollment information.

Where is the NCT05827406 trial being conducted?

This trial is being conducted at Stockholm, Sweden, Stockholm, Sweden, Stockholm, Sweden, Stockholm, Sweden and 1 additional location.

Who is sponsoring the NCT05827406 clinical trial?

NCT05827406 is sponsored by Karolinska Institutet. The principal investigator is Mats O Adler, MD at Karolinska Institutet, Department of Clinical Neuroscience. The trial plans to enroll 2,200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology